Kodiak Sciences KOD
NASDAQ KOD
$35.31 -1.05 (-2.89%)
As of: Sep 4, 2026 · 3:12 PM EDT

Kodiak Sciences (KOD) Non Operating Interest Expenses (2017 - 2023)

Analysis

Kodiak Sciences (KOD) Non Operating Interest Expenses (2017 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Vertex Pharmaceuticals 138.58 Bn 130.73 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.33 Bn 77.33 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.43 Bn 58.24 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.84 Bn 52.70 Bn 52.00 Mn -
5 Revolution Medicines 44.01 Bn 44.01 Bn - 23.78 Mn
6 BeOne Medicines 39.93 Bn 34.83 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.47 Bn 32.16 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.39 Bn 27.56 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 5,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 4,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 5,000.00
Mar 31, 2022 5,000.00
Dec 31, 2021 30,000.00
Sep 30, 2021 6,000.00
Jun 30, 2021 5,000.00
Mar 31, 2021 6,000.00
Dec 31, 2020 6,000.00
Sep 30, 2020 6,000.00
Jun 30, 2020 6,000.00
Mar 31, 2020 7,000.00
Sep 30, 2019 2,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 4,000.00
Dec 31, 2018 190,000.00
Sep 30, 2018 1.98 Mn